Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurisco Pharmaceutical CoSHSE:605116 -1.88%78 OCF Margin % is 22.67% as of Mar. 2026, which is 9% below its 10-year median of 24.96. GuruFocus rates SHSE:605116 with a GF Score™ of 78/100 and a GF Value™ of ¥28.92 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 950 Biotechnology companies, Aurisco Pharmaceutical Co ranks better than 88.53% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:605116 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, Aurisco Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurisco Pharmaceutical Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aurisco Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Aurisco Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurisco Pharmaceutical Co (SHSE:605116) has a OCF Margin % of 22.67% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aurisco Pharmaceutical Co and its competitors. This is near median its historical median of 24.96. Over the past decade, Aurisco Pharmaceutical Co's OCF Margin % has ranged from 16.51 to 31.89. According to the industry distribution chart, Aurisco Pharmaceutical Co ranks #109 out of 950 companies in the Biotechnology industry, placing it in the top 11.5%.
Is Aurisco Pharmaceutical Co's OCF Margin % too high?
Aurisco Pharmaceutical Co's current OCF Margin % of 22.67% is near median its 10-year median of 24.96. Over the past 10 years, this metric has ranged from a low of 16.51 to a high of 31.89. Based on the distribution chart, Aurisco Pharmaceutical Co ranks #109 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Aurisco Pharmaceutical Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurisco Pharmaceutical Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aurisco Pharmaceutical Co ranks #109 out of 950 companies for OCF Margin %. This places Aurisco Pharmaceutical Co in the top 12% of its industry — outperforming the majority of peers. Historically, Aurisco Pharmaceutical Co's own OCF Margin % has ranged from 16.51 to 31.89 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aurisco Pharmaceutical Co and its competitors. Aurisco Pharmaceutical Co's current OCF Margin % is 22.67%, which is near median its own 10-year median of 24.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurisco Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Aurisco Pharmaceutical Co (SHSE:605116) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥28.92, compared to a current price of ¥18.74 — trading 35.2% below its estimated fair value. The current OCF Margin % is 22.67%, which is near median its 10-year median of 24.96. Aurisco Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aurisco Pharmaceutical Co (SHSE:605116), the current OCF Margin % is 22.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurisco Pharmaceutical Co (SHSE:605116) Overvalued in 2026?
Based on GuruFocus' analysis, Aurisco Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥18.74 is trading 35.2% below its estimated GF Value™ of ¥28.92.
GuruFocus considers Aurisco Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:605116:
OCF Margin %: 22.67% (near median its 10-year median of 24.96)
GF Value™: ¥28.92 vs. price of ¥18.74 (35.2% below fair value)
No single metric tells the full story. See the SHSE:605116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
78GF Score
Get the complete analysis for SHSE:605116
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605116 has been successfully added to your 
